Atypical Meningioma

• CLINICAL_TRIALS trial_result · 2025-07-02
  Clinical Trial Update: Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma [NA]

  Clinical trial update on the Optune NovoTTF-100A device for recurrent atypical and anaplastic meningioma; the pilot study is active but not …

• CLINICAL_TRIALS trial_result · 2025-06-29
  Clinical Trial Update: Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers [Phase 2]

  A Phase 2 trial of nivolumab in patients with recurrent select rare CNS cancers (medulloblastoma, ependymoma, pineal region tumors, choroid …

• CLINICAL_TRIALS research · 2025-03-13
  Clinical Trial Update: Predictive Factors for Survival in Aggressive Meningiomas [NA]

  This entry reports an ongoing clinical study assessing predictors of survival in aggressive meningiomas (including typical, atypical, and an…

• CLINICAL_TRIALS trial_result · 2025-01-22
  Clinical Trial Update: A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma [Phase 2]

  Phase 2 trial of pembrolizumab for refractory atypical and anaplastic meningioma has terminated; results have been posted.

• CLINICAL_TRIALS research · 2024-10-15
  Clinical Trial Update: Apatinib in the Treatment of Recurrent Atypical/malignant Meningioma in Adults [NA]

  Clinical trial update indicating Apatinib is being studied for recurrent atypical or malignant meningioma in adults; the study is currently …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.